![FDA approves new drug for Alzheimer’s disease: ‘Meaningful results’](https://static.foxnews.com/foxnews.com/content/uploads/2024/07/woman-iv.jpg)
FDA approves new drug for Alzheimer’s disease: ‘Meaningful results’
Fox News
The FDA has approved a new medication for people with Alzheimer’s disease. Eli Lilly’s Kisunla (donanemab) is a once-monthly injection intended for adults with early symptomatic Alzheimer's disease.
Eligible patients include those with mild cognitive impairment (MCI) and those who have mild dementia with confirmed amyloid pathology. Melissa Rudy is senior health editor and a member of the lifestyle team at Fox News Digital. Story tips can be sent to melissa.rudy@fox.com.
This is the first medication to target amyloid plaques — the proteins that build up in the brains of Alzheimer’s patients, often impairing memory and cognitive function — with evidence to support stopping therapy when amyloid plaques are removed, the release stated.
More Related News